SecBot SecBot
PRESS-RELEASE ·Filed Apr 10, 2026

PHGE

BiomX
BULLISH
Impact 7/10
Horizonmonths Processed7mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ▲ Bullish

Traders should monitor for future revenue synergies and integration progress with DFSL; the acquisition provides immediate access to mission-critical defense deployments, which could accelerate BiomX's commercialization in the sector despite its small market cap.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$2.89
T+0 close · Apr 10, 2026 · via day close
Latest settled
−89.58%
T+60 · $0.3010
Vs SPY
−99.91%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 10 $2.89entry
  2. T+1 · 7mo ago −9.00%α −9.97% · $2.63
  3. T+5 · 7mo ago −36.33%α −40.84% · $1.84
  4. T+20 · 6mo ago −78.58%α −87.11% · $0.6190
  5. T+60 · 4mo ago −89.58%α −99.91% · $0.3010
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BiomX (PHGE) has completed the acquisition of Zorronet, an AI-powered command-and-control software company, from Water.io, marking its strategic entry into the defense, security, and rescue sector. The deal enhances BiomX's capabilities in real-time threat detection and operational intelligence, leveraging Zorronet's existing contracts with the Israel Defense Forces and critical infrastructure entities.

Key Facts

  • BiomX completed the acquisition of 100% of Zorronet from Water.io.
  • Zorronet develops AI-driven software that integrates video analytics, drones, sensors, and IoT devices into a unified threat detection and response platform.
  • The company has active contracts with the Israel Defense Forces, Israel Railways, Elbit Systems, and international government clients.
  • This acquisition positions BiomX in the growing $44B global command-and-control systems market by 2030.
  • Complements BiomX’s prior option to acquire DFSL, a LADAR/C-UAS technology firm, building a diversified defense and security portfolio.

Financial Impact

Deal value not disclosed, but strategic entry into a high-growth defense sector with existing revenue-generating contracts.

revenuestrategic positioningmarket expansion

Risk Factors

  • Undisclosed deal value raises concerns about potential dilution or balance sheet impact.
  • Execution risk in integrating Zorronet and scaling BiomX’s new defense business line.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3271723

US Market Status

Market Closed · Opens in 4h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 10, 2026